I.H. Khan

1.3k total citations
28 papers, 935 citations indexed

About

I.H. Khan is a scholar working on Nephrology, Surgery and Economics and Econometrics. According to data from OpenAlex, I.H. Khan has authored 28 papers receiving a total of 935 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Nephrology, 6 papers in Surgery and 4 papers in Economics and Econometrics. Recurrent topics in I.H. Khan's work include Dialysis and Renal Disease Management (14 papers), Muscle and Compartmental Disorders (5 papers) and Acute Kidney Injury Research (5 papers). I.H. Khan is often cited by papers focused on Dialysis and Renal Disease Management (14 papers), Muscle and Compartmental Disorders (5 papers) and Acute Kidney Injury Research (5 papers). I.H. Khan collaborates with scholars based in United Kingdom, United States and Norway. I.H. Khan's co-authors include Alison M. MacLeod, N Edward, G. R. D. Catto, LauraW. Fleming, I. S. Henderson, Wendy Metcalfe, Gordon Prescott, K.J. Simpson, C. Daly and Jyoti Baharani and has published in prestigious journals such as The Lancet, Cochrane Database of Systematic Reviews and Nephrology Dialysis Transplantation.

In The Last Decade

I.H. Khan

25 papers receiving 896 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I.H. Khan United Kingdom 13 718 191 167 149 116 28 935
Lilyanna Trpeski Canada 13 538 0.7× 224 1.2× 107 0.6× 154 1.0× 214 1.8× 15 887
Grant Luxton Australia 13 835 1.2× 398 2.1× 129 0.8× 215 1.4× 159 1.4× 23 1.2k
Liliana Bulfone Australia 12 633 0.9× 198 1.0× 201 1.2× 92 0.6× 213 1.8× 17 1.0k
Onyekachi Ifudu United States 20 932 1.3× 253 1.3× 158 0.9× 174 1.2× 162 1.4× 50 1.4k
Mauro Verrelli Canada 14 532 0.7× 161 0.8× 130 0.8× 61 0.4× 84 0.7× 22 666
C. Daly United Kingdom 10 276 0.4× 170 0.9× 106 0.6× 90 0.6× 80 0.7× 22 651
Ken Taub Canada 10 669 0.9× 310 1.6× 277 1.7× 155 1.0× 101 0.9× 10 966
Caitlin Carroll United States 13 874 1.2× 357 1.9× 247 1.5× 131 0.9× 271 2.3× 31 1.4k
CA Jones United States 3 570 0.8× 115 0.6× 69 0.4× 64 0.4× 120 1.0× 9 759
Luigi Manili Italy 13 798 1.1× 368 1.9× 208 1.2× 107 0.7× 232 2.0× 27 895

Countries citing papers authored by I.H. Khan

Since Specialization
Citations

This map shows the geographic impact of I.H. Khan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I.H. Khan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I.H. Khan more than expected).

Fields of papers citing papers by I.H. Khan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I.H. Khan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I.H. Khan. The network helps show where I.H. Khan may publish in the future.

Co-authorship network of co-authors of I.H. Khan

This figure shows the co-authorship network connecting the top 25 collaborators of I.H. Khan. A scholar is included among the top collaborators of I.H. Khan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I.H. Khan. I.H. Khan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Khan, I.H., Andrew J. Tan, Aziz Sheikh, et al.. (2025). Association between income, employment status, and asthma outcomes: a systematic review and meta-analysis. The Lancet Regional Health - Europe. 56. 101367–101367.
3.
Bray, Benjamin, J. Gordon Boyd, C. Daly, et al.. (2013). How safe is renal replacement therapy? A national study of mortality and adverse events contributing to the death of renal replacement therapy recipients. Nephrology Dialysis Transplantation. 29(3). 681–687. 30 indexed citations
4.
Bray, Benjamin, Jessica H. Boyd, C. Daly, et al.. (2012). Vascular access type and risk of mortality in a national prospective cohort of haemodialysis patients. QJM. 105(11). 1097–1103. 71 indexed citations
5.
Ali, Tariq, Atsushi Tachibana, I.H. Khan, et al.. (2011). The changing pattern of referral in acute kidney injury. QJM. 104(6). 497–503. 12 indexed citations
6.
MacLeod, Alison M., et al.. (2007). Epidemiology of chronic kidney disease - a population-based study. Nephrology Dialysis Transplantation. 22. 54–55. 6 indexed citations
7.
Parker, Simon, et al.. (2006). Use of genomic analysis of varicella-zoster virus to investigate suspected varicella-zoster transmission within a renal unit. Journal of Clinical Virology. 36(1). 76–78. 5 indexed citations
8.
Metcalfe, Wendy, I.H. Khan, Gordon Prescott, K. Simpson, & Alison M. MacLeod. (2003). Hospitalization in the first year of renal replacement therapy for end-stage renal disease. QJM. 96(12). 899–909. 52 indexed citations
9.
Caskey, Fergus, Sarah Wordsworth, Frank de Charro, et al.. (2003). Early referral and planned initiation of dialysis: what impact on quality of life?. Nephrology Dialysis Transplantation. 18(7). 1330–1338. 67 indexed citations
10.
Vale, Luke, June D Cody, S Wallace, et al.. (2002). Continuous ambulatory peritoneal dialysis (CAPD) versus hospital or home haemodialysis for end-stage renal disease in adults. Cochrane Database of Systematic Reviews. CD003963–CD003963. 6 indexed citations
11.
Cody, June D, C. Daly, Marion Campbell, et al.. (2002). Frequency of administration of recombinant human erythropoietin for anaemia of end-stage renal disease in dialysis patients. The Cochrane Database of Systematic Reviews. CD003895–CD003895. 7 indexed citations
12.
MacLeod, Alison M., C. Daly, I.H. Khan, et al.. (2001). Cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease. Cochrane Database of Systematic Reviews. CD003234–CD003234. 26 indexed citations
13.
Cody, June D, C. Daly, Marion Campbell, et al.. (2001). Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patients. Cochrane Database of Systematic Reviews. CD003266–CD003266. 27 indexed citations
14.
Khan, I.H.. (1998). Comorbidity: the major challenge for survival and quality of life in end-stage renal disease. Nephrology Dialysis Transplantation. 13(90001). 76–79. 38 indexed citations
15.
Khan, I.H., G. R. D. Catto, N Edward, & Alison M. MacLeod. (1997). Acute renal failure: factors influencing nephrology referral and outcome. QJM. 90(12). 781–785. 67 indexed citations
16.
Khan, I.H., Marion Campbell, Diego Cantarovich, et al.. (1996). Survival on renal replacement therapy in Europe: is there a 'centre effect'?. Nephrology Dialysis Transplantation. 11(2). 300–307. 62 indexed citations
17.
Khan, I.H., Jeanette D. Cheng, G. R. D. Catto, N Edward, & Alison M. MacLeod. (1993). Social Deprivation Indices of Patients on Renal Replacement Therapy (RRT) in Grampian. Scottish Medical Journal. 38(5). 139–141. 7 indexed citations
18.
Khan, I.H., et al.. (1993). Severe lactic acidosis in patient receiving continuous ambulatory peritoneal dialysis.. BMJ. 307(6911). 1056–1057. 12 indexed citations
19.
Khan, I.H., G. R. D. Catto, Alison M. MacLeod, et al.. (1993). Influence of coexisting disease on survival on renal-replacement therapy. The Lancet. 341(8842). 415–418. 191 indexed citations
20.
Khan, I.H., et al.. (1993). Secondary Polycythaemia Associated with Idiopathic Membranous Nephropathy. ˜The œNephron journals/Nephron journals. 64(2). 310–311. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lilyanna Trpeski Breakdown of academic impact, for papers by Grant Luxton Breakdown of academic impact, for papers by Liliana Bulfone Breakdown of academic impact, for papers by Onyekachi Ifudu Breakdown of academic impact, for papers by Mauro Verrelli Breakdown of academic impact, for papers by C. Daly Breakdown of academic impact, for papers by Ken Taub Breakdown of academic impact, for papers by Caitlin Carroll Breakdown of academic impact, for papers by CA Jones Breakdown of academic impact, for papers by Luigi Manili
Rankless by CCL
2026